RavenQuest BioMed Cash Flow Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jul '19 Jul 31, 2019	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016	Oct '15 Oct 31, 2015	Oct '14 Oct 31, 2014
Net Income	-32.35	-30.47	-3.3	-0.08	-0.08	-0.06
Depreciation & Amortization	3.89	1.88	0	-	0	-
Asset Writedown & Restructuring Costs	11.72	11.72	2.25	-	-	-
Stock-Based Compensation	6.03	6.16	0.05	-	-	-
Provision & Write-off of Bad Debts	0.35	0.35	-	-	-	-
Other Operating Activities	3.25	1.22	0.15	-	-	-
Change in Inventory	-0.74	-0.08	-	-	-	-
Change in Accounts Payable	2.04	0.06	-1.42	0.05	0.06	0.02
Change in Other Net Operating Assets	3.02	-1.95	-0.22	-0	-0	0
Operating Cash Flow	-0.93	-11.1	-2.5	-0.03	-0.02	-0.04
Capital Expenditures	-7.17	-12.26	-0	-	-	-
Cash Acquisitions	-0.63	-16.28	-0.16	-	-	-
Other Investing Activities	-	-	-	-	-	0.03
Investing Cash Flow	-7.8	-28.54	-0.16	-	-	0.03
Short-Term Debt Issued	-	-	0.04	0.03	0.01	0.01
Long-Term Debt Issued	-	14.01	-	-	-	-
Total Debt Issued	0.61	14.01	0.04	0.03	0.01	0.01
Short-Term Debt Repaid	-	-0.2	-0.12	-	-	-
Total Debt Repaid	-0.4	-0.2	-0.12	-	-	-
Net Debt Issued (Repaid)	0.21	13.81	-0.08	0.03	0.01	0.01
Issuance of Common Stock	9.76	24.44	6.58	-	-	-
Other Financing Activities	-1.84	-1.62	-0.46	-	-	-
Financing Cash Flow	8.13	36.63	6.03	0.03	0.01	0.01
Net Cash Flow	-0.61	-3.02	3.38	-0	-0.01	0.01
Free Cash Flow	-8.11	-23.36	-2.5	-0.03	-0.02	-0.04
Free Cash Flow Margin	-532.79%	-1858.93%	-2222.11%	-	-	-
Free Cash Flow Per Share	-0.07	-0.26	-0.08	-0.00	-0.00	-0.00
Cash Interest Paid	1.61	0.55	0.01	-	-	-
Levered Free Cash Flow	-3.3	-13.84	-0.18	0	0.01	0.01
Unlevered Free Cash Flow	-1.31	-12.65	-0.09	0	0.01	0.01
Change in Working Capital	6.17	-1.96	-1.64	0.05	0.06	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.